Cancer Medicine: Early View
A Phase 2 Trial of the Multi-targeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer (MTC) | Request PDF
Cancer Medicine: Early View
Cancer Medicine: Early View
Cancer Medicine: Early View
Cancer Medicine: Early View
Cancer Medicine: Early View
Cancer Medicine: Early View
Volume degli abstract
Cancer Medicine: Early View
Cancer Medicine: Early View
Cancer Medicine: Early View
Volume degli abstract
Cancer Medicine: Early View
Cancer Medicine: Early View
Cancer Medicine: Early View
A Phase 2 Trial of the Multi-targeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer (MTC) | Request PDF
Cancer Medicine: Early View
Cancer Medicine: Early View
Cancer Medicine: Early View
Cancer Medicine: Early View
Paper Plain: Making Medical Research Papers Approachable to Healthcare Consumers with Natural Language Processing
Ayshea Brough | Mocho's Blog
